Skip Navigation
Skip to contents

Journal of Microbiology : Journal of Microbiology

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J. Microbiol > Volume 64(2); 2026 > Article
Full article
ITS1-based profiling of the skin mycobiome in truncal acne reveals altered baseline ecology and heterogeneous doxycycline-associated patterns
Nayan Jin1, Woo Jun Sul2, Hye Rim Do2,*, Hei Sung Kim1,*
Journal of Microbiology 2026;64(2):e2512013.
DOI: https://doi.org/10.71150/jm.2512013
Published online: February 28, 2026

1Department of Dermatology, Incheon St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea

2Systems Microbial Ecology Laboratory, Department of Systems Biotechnology, Chung-Ang University, Anseong 17546, Republic of Korea

*Correspondence. Hye Rim Do hyerimdo95@gmail.com Hei Sung Kim hazelkimhoho@gmail.com
• Received: December 18, 2025   • Revised: December 25, 2025   • Accepted: December 26, 2025

© The Microbiological Society of Korea

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 19 Views
  • 1 Download
  • Truncal acne represents a biologically distinct manifestation of acne vulgaris, yet its fungal ecology remains incompletely characterized. Previous work using internal transcribed spacer 2 (ITS2) sequencing suggested that truncal acne is associated with altered fungal richness and Malassezia species composition; however, fungal marker choice may influence ecological inference, particularly in sebaceous skin dominated by Malassezia. In this study, we characterized the truncal skin mycobiome of patients with truncal acne and healthy controls using internal transcribed spacer 1 (ITS1) amplicon sequencing. Skin swabs were collected from the upper back, and fungal communities were analyzed using QIIME 2 with taxonomic assignment against the UNITE v10.0 database. Baseline acne–control differences and doxycycline-associated patterns were evaluated using alpha- and beta-diversity metrics and differential abundance analyses. Doxycycline-associated patterns were assessed using paired, within-patient pre- and post-exposure comparisons. ITS1 profiling demonstrated that truncal acne was associated with altered baseline fungal ecology compared with controls, characterized by reduced alpha diversity and ASV-level differences within Malassezia-dominated communities. Beta-diversity analyses showed substantial overlap between acne and control samples, indicating limited global separation. Following doxycycline exposure, fungal communities remained Malassezia-dominant and did not demonstrate uniform convergence toward control profiles; instead, species- and ASV-level differences were heterogeneous across individuals and exposure durations. Together with prior ITS2-based findings, these results underscore the importance of marker-dependent perspectives when interpreting fungal ecology in sebaceous skin.
Truncal skin is among the most sebaceous and environmentally constrained regions of the human body, characterized by large follicular units, limited ventilation, and frequent occlusion from clothing. In individuals with acne vulgaris, these features create a cutaneous environment that differs from facial skin and may support distinct microbial assemblages (Aly et al., 1978; Otberg et al., 2004; Sandby-Møller et al., 2003). Despite the clinical burden of truncal acne (Ballanger et al., 2023; Menteşoğlu et al., 2025), microbial studies have historically prioritized facial sites, leaving truncal microbial ecology comparatively underexplored.
Fungal communities represent a major but incompletely understood component of the truncal skin ecosystem (Grice and Segre, 2011; Prohic et al., 2016). In sebaceous regions, fungal biomass is dominated by lipid-dependent members of the genus Malassezia, which are adapted to utilize host-derived lipids and persist under conditions of limited nutrient diversity. Malassezia species differ substantially in enzymatic repertoires, lipid-processing capacity, and host immune interactions (Li et al., 2022), suggesting that subtle shifts in community structure—rather than overt overgrowth—may influence inflammatory states (Ayers et al., 2005; Findley et al., 2013; Martínez-Ortega et al., 2024; Park et al., 2021a, 2021b). However, whether truncal acne is associated with alterations in the dominant fungal core versus expansion of rare taxa remains unclear.
Systemic antibiotics, particularly doxycycline, are a cornerstone of therapy for moderate-to-severe truncal acne and are prescribed primarily for antibacterial and anti-inflammatory effects (Woo and Kim, 2022). Although doxycycline has no clinically meaningful antifungal activity, antibiotic exposure may indirectly influence fungal communities by altering bacterial–fungal interactions, sebum availability, or local immune tone. Whether such perturbations reshape the truncal mycobiome, or whether dominant fungal communities remain resilient under antibiotic pressure, has not been well characterized.
Amplicon-based profiling of fungal communities is inherently influenced by marker selection, especially in low-diversity, Malassezia-dominated niches. Different internal transcribed spacer (ITS) regions vary in amplification bias and taxonomic resolution and may emphasize different ecological features of the same community. We previously examined the truncal acne mycobiome using ITS2 sequencing and observed altered fungal richness and species composition in acne lesions. To further interrogate community structure and stability in this setting, we extended this work using ITS1 sequencing, which may preferentially capture dominant and persistent fungal residents.
Here, we used ITS1 amplicon sequencing to characterize baseline truncal mycobiome ecology in acne patients compared with controls and to examine doxycycline-associated patterns using paired, within-patient comparisons. By focusing on dominant community structure and antibiotic-associated deviations from baseline, this study provides a complementary ecological perspective on truncal acne and highlights how marker choice influences interpretation of fungal dynamics in sebaceous skin.
Study population and antibiotic exposure classification
Patients with truncal acne and healthy controls were recruited from Incheon St. Mary’s Hospital, The Catholic University of Korea. Moderate-to-severe truncal acne (Investigator’s Global Assessment [IGA] grades 3–4) involving the chest, shoulders, and/or back was diagnosed by board-certified dermatologists. Healthy controls had no history of truncal acne or other inflammatory skin diseases.
Participants were excluded if they had received systemic or topical antibiotics or antifungals within the preceding three months, as antimicrobial exposure can induce sustained alterations in cutaneous microbial and fungal community structure. Individuals with prior isotretinoin therapy were excluded because of its long-lasting effects on sebaceous gland activity and follicular microenvironments that influence microbial colonization. Pregnant individuals were excluded due to hormonal and immunologic changes affecting skin physiology. Finally, individuals with other inflammatory skin diseases or chronic inflammatory or immunologic conditions were excluded to minimize confounding effects on cutaneous microbiome and mycobiome profiles. Truncal acne was clinically distinguished from Malassezia folliculitis based on lesion morphology and distribution, including the absence of monomorphic pruritic papules or pustules, and an overall presentation inconsistent with fungal folliculitis.
The study was approved by the institutional review board (OC21TISI0158), and all participants provided written informed consent.
Skin swab samples were collected from the upper back using a standardized protocol. All 17 acne patients provided paired baseline (V0) and post-doxycycline samples, with follow-up obtained at variable timepoints (10 patients at V1, 7 at V2, and 1 at V3; one individual contributed samples at more than one follow-up visit) (Table S1). Follow-up visits corresponded to oral doxycycline 100 mg administered twice daily for approximately 6 weeks (V1), 12 weeks (V2), and 18 weeks (V3). Because follow-up timing varied among patients, doxycycline-associated analyses were interpreted as paired, within-subject exposure comparisons rather than formal longitudinal trajectories.
Genomic DNA extraction from skin swabs
Fungal genomic DNA was extracted from skin swab samples using the PureLink® Genomic DNA Mini Kit (Invitrogen, Thermo Fisher Scientific) with bead-beating–assisted lysis. Swabs were incubated in lysozyme digestion buffer at 37°C for 1 h, mechanically disrupted with a stainless-steel bead and proteinase K, and incubated at 55°C for 30 min. DNA purification was performed according to the manufacturer’s protocol, with gDNA eluted in 30 µl elution buffer. DNA quantity and purity were assessed using NanoDrop 2000 and Qubit 4 fluorometers.
Mycobiome amplicon sequencing and library preparation
The ITS1 region was amplified using the 18SF and 5.8S 1R primers containing Illumina adapter overhangs. PCR reactions (25 µl) were performed using KAPA HiFi HotStart ReadyMix with standardized cycling conditions. Amplicons were purified with AMPure XP beads, indexed using the Nextera XT Index Kit (Illumina), pooled, and sequenced on an Illumina MiSeq platform using paired-end 2 × 300 bp chemistry.
Bioinformatics analysis
Sequence data were processed using QIIME 2 (version 2024.10). Paired-end reads were imported, primer sequences were removed using cutadapt, and denoising, dereplication, and merging were performed with DADA2. From 1,114,203 raw reads, 936,628 merged reads were retained to generate an amplicon sequence variant (ASV) table at 100% sequence identity. A phylogenetic tree was constructed using the align-to-tree-mafft-fasttree pipeline, and taxonomy was assigned using a pretrained classify-sklearn classifier against the UNITE database (version 10.0, February 2025 release).
Statistical analysis
Statistical analyses were conducted using QIIME 2 (version 2024.10) and R (version 4.3.2) with the vegan package (version 2.6-10). The ASV table was rarefied to 18,000 reads per sample prior to diversity analyses. Alpha diversity (observed features, Shannon entropy, Pielou’s evenness, and Faith’s phylogenetic diversity) was compared between groups using the Wilcoxon rank-sum test. Beta diversity was assessed using Bray–Curtis dissimilarity and unweighted and weighted UniFrac distances, visualized by principal coordinates analysis, and tested using PERMANOVA.
Because ITS1 is a non-coding, highly variable region with frequent indels, ITS-derived multiple sequence alignments and inferred branch lengths are inherently approximate and should not be interpreted as definitive evolutionary phylogenies. Accordingly, Faith’s PD and UniFrac are reported as tree-informed proxy metrics (sensitivity analyses) to complement non-phylogenetic measures (e.g., Bray–Curtis), and interpretations emphasize concordance across metrics rather than phylogenetic inference from ITS-derived trees.
For doxycycline-associated analyses, pre- and post-exposure samples were compared within matched patients. Because the study was not designed or powered for formal longitudinal modeling, these analyses were interpreted as paired, within-subject exposure comparisons. Differentially abundant ASVs were identified using LEfSe (Kruskal–Wallis test, p < 0.05). An LDA threshold of 3.0 was applied for baseline acne–control comparisons, while lower thresholds (LDA > 2.0) were used for doxycycline-associated analyses, which were interpreted as exploratory and hypothesis-generating. Because LEfSe screens a large number of features and we did not apply a formal multiple-testing correction, ASV-level LEfSe results are presented as exploratory/hypothesis-generating candidates rather than definitive biomarkers. A two-sided p-value < 0.05 was considered statistically significant.
Baseline truncal acne mycobiome differs from healthy controls
At baseline (V0), truncal skin fungal communities in both acne patients and healthy controls were dominated by members of the genus Malassezia. ITS1-based alpha-diversity analysis demonstrated significantly lower fungal diversity in acne samples compared with controls, as reflected by reduced observed ASVs, Shannon diversity, Pielou’s evenness, and Faith’s phylogenetic diversity (Fig. 1). These findings indicate that truncal acne is associated with altered baseline fungal ecology characterized by reduced richness and evenness within Malassezia-dominated communities.
Beta diversity reveals relative abundance-driven differences with shared dominant taxa
Principal coordinates analysis based on Bray–Curtis dissimilarity revealed a statistically significant difference in fungal community composition between baseline acne and control samples (PERMANOVA, p < 0.05) (Fig. 2A). In contrast, UniFrac-based analyses demonstrated substantial overlap between groups, with weaker separation observed for weighted UniFrac distances (Fig. 2B). Given the approximate nature of ITS-derived trees, UniFrac results are interpreted as complementary, tree-informed sensitivity analyses rather than definitive evidence of phylogenetic restructuring. This pattern indicates that truncal acne is associated with differences in relative abundance and ASV composition rather than replacement of dominant fungal taxa, consistent with perturbation of a shared fungal core.
Taxonomic composition and differential ASV abundance at baseline
Species-level taxonomic profiling confirmed strong Malassezia dominance in both acne and control samples (Fig. 3A). Although overall genus-level composition was similar, acne samples exhibited greater heterogeneity in species and ASV distribution. LEfSe analysis identified multiple candidate ASVs that were differentially abundant between acne and control groups (Kruskal–Wallis p < 0.05, LDA > 3.0) (Fig. 3B).
Doxycycline exposure is not associated with global restructuring of the truncal mycobiome
All acne patients provided paired baseline (V0) and post-treatment samples following oral doxycycline therapy (100 mg twice daily), with follow-up categorized as V1 (6 weeks), V2 (12 weeks), or V3 (18 weeks). Across exposure durations, no significant changes in fungal alpha diversity were observed in paired pre- and post-treatment comparisons (Fig. 4A), indicating stability of overall fungal richness and evenness following antibiotic exposure.
Beta-diversity analyses further supported community stability following doxycycline treatment. Ordination based on Bray–Curtis and UniFrac distances showed substantial overlap between pre- and post-treatment samples, with no statistically significant global separation detected (PERMANOVA and ANOSIM, p > 0.05) (Fig. 4B). These findings suggest that doxycycline exposure does not induce large-scale restructuring of the truncal fungal community.
Doxycycline exposure is associated with heterogeneous ASV-level differences
Paired comparisons between baseline (V0) and post-doxycycline samples (V1, V2, or V3) revealed heterogeneous species- and ASV-level differences following antibiotic exposure. However, these post-treatment communities did not demonstrate uniform convergence toward control-like profiles and were not accompanied by consistent shifts in global beta-diversity structure (Fig. 5A). LEfSe analysis using a lower threshold (Kruskal–Wallis p < 0.05, LDA > 2.0) identified exploratory, hypothesis-generating ASV-level candidates associated with doxycycline exposure status (Fig. 5B).
Using ITS1 amplicon sequencing, we demonstrate that truncal acne is associated with altered baseline fungal ecology compared with healthy truncal skin, characterized by reduced alpha diversity and ASV-level differences within Malassezia-dominated communities. These findings suggest perturbation within a largely conserved fungal framework rather than replacement of core taxa, indicating that disease-associated differences occur primarily at finer taxonomic resolution.
Doxycycline-associated analyses in this study reflect paired, within-patient comparisons between baseline (V0) and post-treatment samples obtained after clinically relevant exposure durations. Across exposure groups, fungal communities remained Malassezia-dominant and did not exhibit global restructuring or convergence toward control profiles, indicating relative resilience of the truncal mycobiome to indirect antibiotic pressure. Nevertheless, paired analyses identified heterogeneous ASV-level differences across individuals, consistent with fine-scale variation rather than uniform community remodeling. Accordingly, doxycycline-associated findings should be interpreted cautiously.
An important consideration in interpreting these results is the choice of fungal marker. The ITS1-based patterns observed here differ in several respects from our prior ITS2-based analysis of the same cohort, which identified increased fungal richness and clearer beta-diversity separation in truncal acne. Rather than representing contradictory findings, these differences likely reflect marker-dependent resolution of distinct ecological layers within Malassezia-dominated communities. In sebaceous skin, where fungal diversity is inherently low and communities are dominated by lipid-dependent taxa, ITS1 profiling may preferentially capture dominant and stable fungal residents, providing a conservative representation of core community structure. In contrast, ITS2-based approaches may be more sensitive to low-abundance or transient taxa and thus accentuate differences in richness or community separation. Viewed together, ITS1 and ITS2 offer complementary, marker-dependent perspectives on truncal fungal ecology rather than interchangeable measures (Bellemain et al., 2010; Findley et al., 2013; Jagielski et al., 2014; Jo et al., 2016).
This study has several limitations, including variable follow-up timing, absence of bacterial or functional profiling, and lack of direct sebum measurements. In addition, potential truncal-specific confounders—such as bathing habits, topical product use, clothing occlusion, physical activity, and seasonality—were not formally controlled. Finally, the control cohort was female-predominant, which may limit inference regarding sex-associated variation. Future studies incorporating longitudinal designs, multi-kingdom profiling, and sex-balanced control cohorts are warranted to further clarify fungal dynamics in truncal acne. In addition, phylogeny-informed metrics derived from ITS1 amplicons rely on approximate alignments and inferred trees; therefore, Faith’s PD and UniFrac are interpreted as complementary, tree-informed proxies rather than definitive phylogenetic estimates.
The online version contains supplementary material available at https://doi.org/10.71150/jm.2512013.
Table S1.
Demographic data on the truncal acne and control population
jm-2512013-Supplementary-Table-S1.pdf
Fig. 1.
Baseline truncal acne mycobiome differs from healthy controls. ITS1-based alpha-diversity analysis demonstrated significantly lower fungal diversity in acne samples compared with controls, as reflected by reduced observed ASVs, Shannon diversity, Pielou’s evenness, and Faith’s phylogenetic diversity.
jm-2512013f1.jpg
Fig. 2.
Beta diversity reveals relative abundance-driven differences with shared dominant taxa.
jm-2512013f2.jpg
Fig. 3.
Taxonomic composition and differential ASV abundance at baseline.
jm-2512013f3.jpg
Fig. 4.
Global truncal mycobiome structure is stable after doxycycline exposure.
jm-2512013f4.jpg
Fig. 5.
Heterogeneous ASV-level differences after doxycycline exposure.
jm-2512013f5.jpg
  • Aly R, Shirley C, Cunico B, Maibach HI. 1978. Effect of prolonged occlusion on the microbial flora, pH, carbon dioxide and transepidermal water loss on human skin. J Invest Dermatol. 71: 378–381. ArticlePubMed
  • Ayers K, Sweeney SM, Wiss K. 2005. Pityrosporum folliculitis: diagnosis and management in 6 female adolescents with acne vulgaris. Arch Pediatr Adolesc Med. 159: 64–67. ArticlePubMed
  • Ballanger F, Claudel JP, Leccia MT, Auffret N, Stromstedt Camerati A, et al. 2023. Truncal acne in adolescents and young adults: self-reported perception. Acta Derm Venereol. 103: adv5123.ArticlePubMedPMCLink
  • Bellemain E, Carlsen T, Brochmann C, Coissac E, Taberlet P, et al. 2010. ITS as an environmental DNA barcode for fungi: an in silico approach reveals potential PCR biases. BMC Microbiol. 10: 189.ArticlePubMedPMC
  • Findley K, Oh J, Yang J, Conlan S, Deming C, et al. 2013. Topographic diversity of fungal and bacterial communities in human skin. Nature. 498: 367–370. ArticlePubMedPMCPDF
  • Grice EA, Segre JA. 2011. The skin microbiome. Nat Rev Microbiol. 9: 244–253. ArticlePubMedPMCPDF
  • Jagielski T, Rup E, Ziółkowska A, Roeske K, Macura AB, et al. 2014. Distribution of Malassezia species on the skin of patients with atopic dermatitis, psoriasis, and healthy volunteers assessed by conventional and molecular identification methods. BMC Dermatol. 14: 3.ArticlePubMedPMCPDF
  • Jo JH, Deming C, Kennedy EA, Conlan S, Polley EC, et al. 2016. Diverse human skin fungal communities in children converge in adulthood. J Invest Dermatol. 136: 2356–2363. ArticlePubMedPMC
  • Li W, Wang T, Huang WB, Li FG, Quan JH, et al. 2022. Malassezia globosa activates NLRP3 inflammasome in human sebocytes. J Invest Dermatol. 142: 2042–2046. ArticlePubMed
  • Martínez-Ortega JI, Mut Quej JE, Franco González S. 2024. Malassezia folliculitis: pathogenesis and diagnostic challenges. Cureus. 16: e73429. PubMedPMC
  • Menteşoğlu D, Kurmuş GI, Kartal SP. 2025. Investigating the properties of truncal acne: a common but often overlooked entity. J Cutan Med Surg. 29: 480–484. ArticlePubMedLink
  • Otberg N, Richter H, Schaefer H, Blume-Peytavi U, Sterry W, et al. 2004. Variations of hair follicle size and distribution in different body sites. J Invest Dermatol. 122: 14–19. ArticlePubMed
  • Park HR, Oh JH, Lee YJ, Park SH, Lee YW, et al. 2021a. Inflammasome-mediated inflammation by Malassezia in human keratinocytes: a comparative analysis with different strains. Mycoses. 64: 292–299. ArticleLink
  • Park M, Park S, Jung WH. 2021b. Skin commensal fungus Malassezia and its lipases. J Microbiol Biotechnol. 31: 637–644. Article
  • Prohic A, Jovovic Sadikovic T, Krupalija-Fazlic M, Kuskunovic-Vlahovljak S. 2016. Malassezia species in healthy skin and in dermatological conditions. Int J Dermatol. 55: 494–504. ArticlePubMed
  • Sandby-Møller J, Poulsen T, Wulf HC. 2003. Epidermal thickness at different body sites: relationship to age, gender, pigmentation, blood content, skin type and smoking habits. Acta Derm Venereol. 83: 410–413. ArticlePubMed
  • Woo YR, Kim HS. 2022. Truncal acne: an overview. J Clin Med. 11: 3660.ArticlePubMedPMC

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      • ePub LinkePub Link
      • Cite this Article
        Cite this Article
        export Copy Download
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        ITS1-based profiling of the skin mycobiome in truncal acne reveals altered baseline ecology and heterogeneous doxycycline-associated patterns
        J. Microbiol. 2026;64(2):e2512013  Published online February 28, 2026
        Close
      • XML DownloadXML Download
      Figure
      ITS1-based profiling of the skin mycobiome in truncal acne reveals altered baseline ecology and heterogeneous doxycycline-associated patterns
      Image Image Image Image Image
      Fig. 1. Baseline truncal acne mycobiome differs from healthy controls. ITS1-based alpha-diversity analysis demonstrated significantly lower fungal diversity in acne samples compared with controls, as reflected by reduced observed ASVs, Shannon diversity, Pielou’s evenness, and Faith’s phylogenetic diversity.
      Fig. 2. Beta diversity reveals relative abundance-driven differences with shared dominant taxa.
      Fig. 3. Taxonomic composition and differential ASV abundance at baseline.
      Fig. 4. Global truncal mycobiome structure is stable after doxycycline exposure.
      Fig. 5. Heterogeneous ASV-level differences after doxycycline exposure.
      ITS1-based profiling of the skin mycobiome in truncal acne reveals altered baseline ecology and heterogeneous doxycycline-associated patterns

      Journal of Microbiology : Journal of Microbiology
      TOP